ASAH1 levels are also elevated in the subpopulation of GBM cells known as glioblastoma stem-like cells, which express the neural and brain cancer stem cell marker CD133, which in turn is associated with poor prognosis if expressed at high levels [165,166,167,168,169,170,171]. This evidence concerns the gene ASAH1 and glioblastoma.